| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0015 | 1 |